David Sinclair· PhD
And there are other NAD boosting molecules that have been made that are even better than NMN. So-called NCEs called, new chemical entities. And those I'm aware of probably in the next year will go into the first human study.
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
And there are other NAD boosting molecules that have been made that are even better than NMN. So-called NCEs called, new chemical entities. And those I'm aware of probably in the next year will go into the first human study.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.